Japanese drugmaker Shionogi plans to acquire Torii Pharmaceutical for about 150 billion yen ($1.01 billion), the Nikkei ...

DoorDash swung to a first-quarter profit as demand continued to grow for online restaurant and grocery-store orders, and the ...

The 55% decline in the stock from its 2021 high, combined with the company's consistent revenue growth since then, has pushed ...

Sixth Street’s investment in Bill Chisholm’s $6.1 billion bid to buy the team is as much about prestige as it is owning a ...

Delta Air Lines announced a $1 billion share repurchase program, but it doesn't significantly impact the price target. Learn ...

Should you jump on the latest stock splits? Some make sense and others don't. Here's what you need to know about two recent ...

Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Analysts are feeling positive about these shares. Let's see what they are forecasting for them. The post 3 growing ASX ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

Palantir Technologies Inc.'s stock dip signals a buying opportunity for long-term investors. Click here to find out why I ...

Snapping previous session gains, shares of SBI declined as much as 2% to hit an intraday low of ₹783.65 on the BSE, while the ...

Although the majority of brokerage firms maintain a bullish stance on the stock, a number of them have revised their earnings ...